Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
23 July 1987Website:
http://www.conmed.comNext earnings report:
31 January 2025Last dividends:
16 September 2024Next dividends:
N/APrice
after hours | 15 min agoAnalysts recommendations
Institutional Ownership
Included in screeners
CNMD Latest News
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat J. Beyer, Chief Operating Officer, will participate in a fireside chat at the Piper Sandler Healthcare Conference at 12:30 p.m. ET on Tuesday, December 3, 2024. A live video webcast of the fireside chat will be accessible through the “Investors” section of the Company's website at.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CNMD's Q3 earnings beat estimates on the back of higher revenues and lower costs and expenses.
The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Conmed (CNMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Conmed (CNMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CNMD is poised for growth with strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.
Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "Carpal Tunnel Release Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Carpal Tunnel Release Systems was estimated at US$604.4 Million in 2023, and is projected to reach US$809.7 Million by 2030, growing at a CAGR of 4.3% from 2023 to 2030. The growth in the carpal tunnel release systems market is driven by several factors, including technological advancements, an increase in the prevalence of conditions requiring such interventions, and heightened patient preference for minimally invasive procedures. The continuous development of new technologies such as enhanced endoscopic equipment and improved surgical techniques contributes significantly to the efficacy and safety of carpal tunnel surgeries, appealing to both surgeons and patients.
CONMED (CNMD) beats second-quarter earnings estimates on the back of higher revenues and lower costs and expenses. However, the result reflects the continued impact of supply chain issues.
What type of business is CONMED?
CONMED Corporation is a global company in the field of medical technology, specializing in the development, manufacture, and sale of surgical equipment. It was founded in 1970. The headquarters are located in Largo, Florida (USA). CONMED Corporation produces two product lines: Orthopedic surgery - products for joint trauma recovery, implants, electrically powered surgical instruments, tissue recovery kits, as well as related disposable items (razor blades, drills, and pump tubes). General surgery - a wide range of products in the field of surgical, endoscopic technologies, and intensive care: devices for hemostasis, treatment of biliary structures, and cardiac monitoring, including electrodes for ECG and EEG, defibrillation pads, graspers, scissors, dissectors, and others used in minimally invasive surgery.
What sector is CONMED in?
CONMED is in the Healthcare sector
What industry is CONMED in?
CONMED is in the Medical Devices industry
What country is CONMED from?
CONMED is headquartered in United States
When did CONMED go public?
CONMED initial public offering (IPO) was on 23 July 1987
What is CONMED website?
https://www.conmed.com
Is CONMED in the S&P 500?
No, CONMED is not included in the S&P 500 index
Is CONMED in the NASDAQ 100?
No, CONMED is not included in the NASDAQ 100 index
Is CONMED in the Dow Jones?
No, CONMED is not included in the Dow Jones index
When was CONMED the previous earnings report?
No data
When does CONMED earnings report?
The next expected earnings date for CONMED is 31 January 2025